Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Effi Setiawati"'
Autor:
Ratih S. I. Putri, Effi Setiawati, Syifa A. Aziswan, Fenny Ong, Raymond R. Tjandrawinata, Liana W. Susanto
Publikováno v:
Scientia Pharmaceutica, Vol 84, Iss 4, Pp 715-723 (2016)
The present study aimed to compare pharmacokinetic parameters of two pramipexole 0.25 mg formulations in order to show bioequivalence. The study was conducted in a randomized, open-label, two-period, two-sequence, and crossover design, involving 23 h
Externí odkaz:
https://doaj.org/article/6556de8a8c7f4ba78e156bb213d443c3
Autor:
Effi Setiawati, Indri Rooslamiati, Lanny Marliany, Ani Isnawati, Vivi Setiawaty, Retno Gitawati, Mariana Raini
Publikováno v:
Bali Medical Journal, Vol 7, Iss 2, Pp 290-295 (2018)
Background: Malaria is still considered as a major health problem in the world including in Indonesia, which is regarded as one of the malaria-endemic countries. Since 2006, WHO has recommended the use of artemisinin-based combination therapy (ACT) t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19bcbbcfb6b04f5ee7a2b40e76fd53ad
https://balimedicaljournal.org/index.php/bmj/article/view/822
https://balimedicaljournal.org/index.php/bmj/article/view/822
Publikováno v:
Clinical Pharmacology : Advances and Applications
Raymond R Tjandrawinata,1 Arini Setiawati,2 Dwi Nofiarny,1 Liana W Susanto,1 Effi Setiawati3 1Dexa Laboratories of Biomolecular Sciences Unit, Dexa Medica Group, Cikarang, West Java, Indonesia; 2Department of Pharmacology and Therapeutics, Medical Fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20a99329b43d9137af90065b9a985171
https://doi.org/10.2147/cpaa.s161024
https://doi.org/10.2147/cpaa.s161024
Autor:
Liana W Susanto, Raymond R. Tjandrawinata, Ratih Sofia Ika Putri, Syifa A Aziswan, Effi Setiawati, Fenny Ong
Publikováno v:
Scientia Pharmaceutica, Vol 84, Iss 4, Pp 715-723 (2016)
Scientia Pharmaceutica
Volume 84
Issue 4
Pages 715-723
Scientia Pharmaceutica
Volume 84
Issue 4
Pages 715-723
The present study aimed to compare pharmacokinetic parameters of two pramipexole 0.25 mg formulations in order to show bioequivalence. The study was conducted in a randomized, open-label, two-period, two-sequence, and crossover design, involving 23 h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4a40473ebc7d2269539297ffb4c890e
http://www.mdpi.com/2218-0532/84/4/715
http://www.mdpi.com/2218-0532/84/4/715
Autor:
Danang Agung Yunaidi, Iwan Dwi Santoso, Liana W Susanto, Arini Setiawati, Raymond R. Tjandrawinata, Effi Setiawati
Publikováno v:
Drug Design, Development and Therapy
Raymond R Tjandrawinata,1 Effi Setiawati,2 Danang Agung Yunaidi,2 Iwan Dwi Santoso,2 Arini Setiawati,3 Liana W Susanto11Dexa Laboratories of Biomolecular Sciences (DLBS), Cikarang, Indonesia; 2Bioavailability and Bioequivalence Laboratory, Equilab In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1023cee0c2af8fb2496dc4d831ab3229
http://europepmc.org/articles/PMC3489052
http://europepmc.org/articles/PMC3489052
Autor:
Gunawan Harinanto, Lucia Rat Handayani, Effi Setiawati, Iwan Dwi Santoso, Atika Rimainar, Danang Agung Yunaidi, Siti Hawa Deniati, Asriningtyas Purnomo Sari
Publikováno v:
Arzneimittelforschung. 59:471-475
The study was conducted to find out whether the bioavailability of a 500 mg azithromycin (CAS 83905–01–5) tablet (Zycin®, test) was equivalent to that of a reference formulation. The pharmacokinetic parameters assessed in this study were the are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf6692effd5b07100234d6058fe900f8
https://doi.org/10.1055/s-0031-1296427
https://doi.org/10.1055/s-0031-1296427
Autor:
Arini Setiawati, Siti Hawa Deniati, Joan Aprilla Arland, Danang Agung Yunaidi, Lai Yeo Lian, Effi Setiawati, Lucia Rat Handayani, Iwan Dwi Santoso
Publikováno v:
Arzneimittelforschung. 61:234-238
The present study was performed to compare the bioavailability of two perindopril erbumine (CAS 107133-36-8) 4 mg tablet formulations (test formulation and reference formulation). This study was a randomized, single-blind, two-period, two-sequence cr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b6d43aa00be242a5e4110ecb11311c2
https://doi.org/10.1055/s-0031-1296193
https://doi.org/10.1055/s-0031-1296193
Autor:
Fawzia Amalia, Ratih Sofia Ika Putri, Effi Setiawati, Liana W Susanto, Raymond R. Tjandrawinata, Danang Agung Yunaidi
Publikováno v:
Drug Design, Development and Therapy
Raymond R Tjandrawinata,1 Effi Setiawati,2 Ratih Sofia Ika Putri,2 Danang Agung Yunaidi,2 Fawzia Amalia,2 Liana W Susanto1 1Dexa Laboratories of Biomolecular Sciences, Cikarang, Indonesia; 2PT Equilab International, Bioavailability and Bioequivalence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::873f4b54f03dbb4537f139f7b77a79d3
https://www.dovepress.com/single-dose-pharmacokinetic-equivalence-study-of-two-gabapentin-prepar-peer-reviewed-article-DDDT
https://www.dovepress.com/single-dose-pharmacokinetic-equivalence-study-of-two-gabapentin-prepar-peer-reviewed-article-DDDT
Bioequivalence study of two risedronate sodium film-coated tablet formulations in healthy volunteers
Autor:
B. S. Utami, A. B. Sholeh, Danang Agung Yunaidi, T. A. Rosa, R. Simanjuntak, Effi Setiawati, Arini Setiawati, Lucia Rat Handayani
Publikováno v:
Drug research. 64(3)
The present study was performed to compare the bioavailability of 2 risedronate sodium 35 mg film-coated tablet formulations (test formulation and reference formulation). Prior to the present study, in vitro comparative dissolution test has been cond
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2347ae11e99a5e1ee92b6f064dd3c558
https://pubmed.ncbi.nlm.nih.gov/24002927
https://pubmed.ncbi.nlm.nih.gov/24002927
Autor:
Raymond R. Tjandrawinata, Ronal Simanjuntak, Liana W Susanto, Iwan Dwi Santoso, Effi Setiawati, Danang Agung Yunaidi
Publikováno v:
Drug Design, Development and Therapy
Raymond R Tjandrawinata,1 Effi Setiawati,2 Danang Agung Yunaidi,2 Ronal Simanjuntak,2 Iwan Dwi Santoso,2 Liana W Susanto1 1Dexa Laboratories of Biomolecular Sciences (DLBS), Cikarang, Indonesia; 2Bioavailability and Bioequivalence Laboratory, PT Equi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ef46fd87920f7b798df19421bed1015
https://pubmed.ncbi.nlm.nih.gov/23990709
https://pubmed.ncbi.nlm.nih.gov/23990709